The core of the speech held by Lucio Zaghetto – the ASAlaser Scientific & Educational Director – during the seminar on “Modern technology for surgery and rehabilitation in patients with spinal column and spinal cord pathologies” held at the Burdenko National Scientific and Practical Center for Neurosurgery in Moscow, centred on disseminating knowledge of the effectiveness of the ASAlaser therapies (Hilterapia®, MLS® Laser Therapy and Qs Magnetotherapy) for rehabilitating patients with spinal issues. The facility, which is also the headquarters of the Russian National Centre for Neurosurgery research, welcomed the sector specialists who gained knowledge concerning the use of the company’s therapeutic solutions when treating often complex pathologies thanks to the ASA speech "The emerging field of Laser therapy and Magnetotherapy in rehabilitation". “In addition to representing a source of pride, the invitation by this internationally renowned facility – explains Zaghetto – has allowed to further strengthen our ties with the Russian market, where our therapies are already adopted by leading experts in first-class clinics and hospitals. An example is provided by Prof Nikolay Konovalov, Chairman of the spinal neurosurgical department of the Burdenko Center and member of the Russian Academy of science, who invited us to analyse their use with doctors and therapists in his department”. The meeting consisted of a theoretical session and a practical one with demonstrations on actual patients which allowed those present to concretely verify not only the results which can be obtained already from the first session, but also the ease of use of the ASAlaser devices. “The interest shown towards Hilterapia® by this organisation which represents the greatest neurosurgery clinical centre in the world – as is pointed out by Giacomo Granozio, the ASAlaser Area Manager - is also the result of the work carried out during the past years by our staff and by that of Beka Rus, our partner. Work which mainly focuses on building up a both informed and professional laser therapy culture”.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.